eli lilly phase 3 trial retatrutide Today, we shared new data from two trials of retatrutide, our investigational triple agonist. Learn more at our link in bio Retatrutide Delivers Bariatric-Level Weight Loss

These findings highlight the potential clinical importance of achieving and maintaining weight loss after GLP-1-based treatment initiation. Meeting: European Congress on Obesity 2026 (ECO2026) Never miss a breakthrough: Join the SciTechDaily newsletter

Injection site: Tracks your rotation schedule and helps identify if absorption variations between sites affect your response

Losing excess weight can enhance insulin sensitivity, reduce inflammation, and improve cardiovascular health

Clean Your Workspace: Before you begin, make sure your hands and workspace are clean to minimize the risk of contamination

Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimers and Parkinsons diseases